Interview with Chi-Chao Chan. Interview by Isaac Bruce
Insights
Dr. Chi-Chao Chan researches intraocular lymphoma, uveitis, and age-related macular degeneration. Her work highlights challenges in ophthalmic research and potential for new drugs with an aging population.
Area of Science:
- Ophthalmology
- Immunopathology
- Molecular Pathology
Background:
- Dr. Chi-Chao Chan, a board-certified ophthalmologist, leads research at the National Eye Institute.
- Her expertise spans primary intraocular lymphoma, uveitis, and age-related macular degeneration (AMD).
Observation:
- Current research focuses on the molecular pathology, animal models, and genetic epidemiology of AMD.
- Dr. Chan's work addresses challenges in ophthalmic research.
Findings:
- The aging population presents opportunities for developing novel therapeutic agents for eye diseases.
- Understanding the molecular and genetic factors of AMD is crucial for targeted drug development.
Implications:
- Advances in understanding intraocular inflammatory diseases and lymphoma can improve patient outcomes.
- Future medicinal chemistry holds promise for innovative treatments for age-related eye conditions.
Abstract:
Chi-Chao Chan, an American board certified ophthalmologist, is the Chief of Immunopathology Section, Laboratory of Immunology and the Head of Histology Core at the National Eye Institute at National Institutes of Health (USA). In 1967, Dr Chan graduated from Chungzhan Medical College in Guangzhou, China and then earned her AB (1972), as well as MD (1975) at Johns Hopkins University (USA). Currently, her research is focusing on primary intraocular (vitreoretinal) lymphoma; uveitis (intraocular inflammatory diseases); and the molecular pathology, animal models, and genetic epidemiology of age-related macular degeneration. Dr Chan spoke to Future Medicinal Chemistry, about the challenges ophthalmic research faces and how the aging population could lead to better drugs.
Related Concept Videos
Interference and Diffraction
iChip
Finding Critical Values for Chi-Square
Chi-square Analysis
The chi-square test was developed by Pearson in 1990.
The first step of performing a Chi-square analysis is to establish a null hypothesis, which assumes that there is no real...
The Stanford Prison Experiment
Atomic Force Microscopy
The AFM Probe
The probe is regarded as the heart of any AFM setup and comprises the...


